Delivery Order SPE2DB20D3505-SPE2DB25FYCSB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,579.61 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contraceptive pharmaceutical product will support federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order valued at $1,068.08 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on September 4, 2025, with completion expected by September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The etonogestrel-EE vaginal ring is a hormonal contraceptive product used...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Etonogestrel-EE vaginal rings, valued at $3,009.21. The delivery order, issued on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings valued at $1,793.40 under a firm fixed price contract type. The award, made on August 12, 2025, represents a single delivery order with an ultimate completion date of August 13, 2025, and involves no set-aside designation, indicating competitive award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,076.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of June 23, 2025. This non-set-aside contract represents a small-value delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement running...
- The Defense Logistics Agency (DLA) awarded a $12,219.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of September 23, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $3,354.82 to AmerisourceBergen Drug Corp for Etonogestrel-EE vaginal rings, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings valued at $2,615.28 under a firm fixed-price contract. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.75 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol (EE) vaginal rings. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order with an ultimate completion date of July 21, 2025. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.77 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCSBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,432.38 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order, with no set-aside designation, represents a routine procurement of a hormonal contraceptive product to support military healthcare needs. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. As a prime vendor in the DLA Medical Supply Chain, AmerisourceBergen supplies a broad spectrum of pharmaceutical products and medical supplies to support military and veteran healthcare systems worldwide. The company's federal contract portfolio demonstrates consistent competitively awarded status across multiple therapeutic domains, positioning it as a critical supplier for Defense Health Agency medical procurement initiatives across various military installations and healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/22/25 |